Australia markets open in 6 hours 3 minutes

Miromatrix Medical Inc. (MIRO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.24+0.13 (+1.86%)
As of 11:07AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 130.85M
Enterprise value 69.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.25k
Price/book (mrq)2.21
Enterprise value/revenue 1.73k
Enterprise value/EBITDA -7.59

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-53.36%
S&P500 52-week change 323.08%
52-week high 316.52
52-week low 36.45
50-day moving average 37.66
200-day moving average 38.95

Share statistics

Avg vol (3-month) 321.66k
Avg vol (10-day) 312.55k
Shares outstanding 520.25M
Implied shares outstanding 6N/A
Float 814.2M
% held by insiders 19.10%
% held by institutions 115.64%
Shares short (14 Nov 2021) 411.44k
Short ratio (14 Nov 2021) 40.82
Short % of float (14 Nov 2021) 40.07%
Short % of shares outstanding (14 Nov 2021) 40.06%
Shares short (prior month 14 Oct 2021) 436.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-34,394.49%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)40.27k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-9.50%
Gross profit (ttm)-453.47k
EBITDA -13.73M
Net income avi to common (ttm)-10.28M
Diluted EPS (ttm)-1.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)62.09M
Total cash per share (mrq)3.07
Total debt (mrq)864.93k
Total debt/equity (mrq)1.46
Current ratio (mrq)17.58
Book value per share (mrq)2.93

Cash flow statement

Operating cash flow (ttm)-10.15M
Levered free cash flow (ttm)N/A